SCYNEXIS, Inc. 135A.F Stock
SCYNEXIS, Inc. Price Chart
SCYNEXIS, Inc. 135A.F Financial and Trading Overview
| SCYNEXIS, Inc. stock price | 2.36 EUR |
| Previous Close | 2.5 EUR |
| Open | 2.46 EUR |
| Bid | 2.46 EUR x N/A |
| Ask | 2.55 EUR x N/A |
| Day's Range | 2.46 - 2.46 EUR |
| 52 Week Range | 1.06 - 3.4 EUR |
| Volume | 1.04K EUR |
| Avg. Volume | 142 EUR |
| Market Cap | 101.36M EUR |
| Beta (5Y Monthly) | 2.128873 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 1.94 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 24.36 EUR |
135A.F Valuation Measures
| Enterprise Value | 90.7M EUR |
| Trailing P/E | N/A |
| Forward P/E | -1.4878788 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 18.3165 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 16.389 |
| Enterprise Value/EBITDA | -1.192 |
Trading Information
SCYNEXIS, Inc. Stock Price History
| Beta (5Y Monthly) | 2.128873 |
| 52-Week Change | 54.11% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.4 EUR |
| 52 Week Low | 1.06 EUR |
| 50-Day Moving Average | 2.6 EUR |
| 200-Day Moving Average | 2.12 EUR |
135A.F Share Statistics
| Avg. Volume (3 month) | 142 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 36.52M |
| Float | 33.36M |
| Short Ratio | N/A |
| % Held by Insiders | 1.87% |
| % Held by Institutions | 52.98% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1385.99% |
| Gross Margin | 87.96% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -52.71% |
| Return on Equity (ttm) | -2024.49% |
Income Statement
| Revenue (ttm) | 5.53M EUR |
| Revenue Per Share (ttm) | 0.12 EUR |
| Quarterly Revenue Growth (yoy) | 64.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | -76099000 EUR |
| Net Income Avi to Common (ttm) | -91234000 EUR |
| Diluted EPS (ttm) | -1.86 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 54.82M EUR |
| Total Cash Per Share (mrq) | 1.5 EUR |
| Total Debt (mrq) | 48.75M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.309 |
| Book Value Per Share (mrq) | -0.898 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -82818000 EUR |
| Levered Free Cash Flow (ttm) | -47228124 EUR |
Profile of SCYNEXIS, Inc.
| Country | Germany |
| State | NJ |
| City | Jersey City |
| Address | 1 Evertrust Plaza |
| ZIP | 07302-6548 |
| Phone | 201 884 5485 |
| Website | https://www.scynexis.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 36 |
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment of fungal infections in the United States. It offers BREXAFEMME for the treatment of vulvovaginal candidiasis (VVC) and recurrent VVC. The company's lead product candidate is Ibrexafungerp, an intravenous drug for the treatment of various fungal infections, including invasive candidiasis, refractory invasive fungal infections, invasive aspergillosis, VVC, and recurrent VVC. It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
Q&A For SCYNEXIS, Inc. Stock
What is a current 135A.F stock price?
SCYNEXIS, Inc. 135A.F stock price today per share is 2.36 EUR.
How to purchase SCYNEXIS, Inc. stock?
You can buy 135A.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for SCYNEXIS, Inc.?
The stock symbol or ticker of SCYNEXIS, Inc. is 135A.F.
Which industry does the SCYNEXIS, Inc. company belong to?
The SCYNEXIS, Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does SCYNEXIS, Inc. have in circulation?
The max supply of SCYNEXIS, Inc. shares is 37.78M.
What is SCYNEXIS, Inc. Price to Earnings Ratio (PE Ratio)?
SCYNEXIS, Inc. PE Ratio is 1.21855680 now.
What was SCYNEXIS, Inc. earnings per share over the trailing 12 months (TTM)?
SCYNEXIS, Inc. EPS is 1.94 EUR over the trailing 12 months.
Which sector does the SCYNEXIS, Inc. company belong to?
The SCYNEXIS, Inc. sector is Healthcare.